Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$2.01B |
| 2 |
Broadcom
AVGO
|
+$1.41B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$978M |
| 4 |
JPMorgan Chase
JPM
|
+$714M |
| 5 |
Tesla
TSLA
|
+$626M |
Top Sells
| 1 |
Honeywell
HON
|
+$1.68B |
| 2 |
Visa
V
|
+$1.41B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$855M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$550M |
Sector Composition
| 1 | Technology | 34.36% |
| 2 | Financials | 12.76% |
| 3 | Consumer Discretionary | 11.44% |
| 4 | Communication Services | 8.74% |
| 5 | Healthcare | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Krispy Kreme
DNUT
$539M
| $441K | ﹤0.01% |
151,547
-17,864
| -11% | -$52K |
|
3027
Citizens Financial Services
CZFS
$311M
| $440K | ﹤0.01% |
7,500
+2,784
| +59% | +$163K |
|
|
KGEI
3028
Kolibri Global Energy
KGEI
$192M
| $440K | ﹤0.01% |
64,363
+46,651
| +263% | +$319K |
|
|
EFSI
3029
Eagle Financial Services Inc Common Stock
EFSI
$200M
| $439K | ﹤0.01% |
+14,292
| New | +$439K |
|
3030
Editas Medicine
EDIT
$244M
| $438K | ﹤0.01% |
199,530
+58,346
| +41% | +$128K |
|
3031
Entravision Communication
EVC
$216M
| $436K | ﹤0.01% |
188,415
+43,083
| +30% | +$99.7K |
|
3032
Precigen
PGEN
$1.24B
| $435K | ﹤0.01% |
306,418
+126,583
| +70% | +$180K |
|
3033
Rayonier Advanced Materials
RYAM
$412M
| $435K | ﹤0.01% |
113,248
+43,472
| +62% | +$167K |
|
|
TECX
3034
Tectonic Therapeutic, Inc. Common Stock
TECX
$337M
| $435K | ﹤0.01% |
21,891
+8,181
| +60% | +$163K |
|
3035
Abeona Therapeutics
ABEO
$346M
| $434K | ﹤0.01% |
76,401
-8,364
| -10% | -$47.5K |
|
|
BRT
3036
BRT Apartments
BRT
$296M
| $434K | ﹤0.01% |
27,733
+16,278
| +142% | +$255K |
|
3037
Limoneira
LMNR
$279M
| $434K | ﹤0.01% |
27,795
+11,138
| +67% | +$174K |
|
3038
Satellogic
SATL
$394M
| $434K | ﹤0.01% |
+119,875
| New | +$434K |
|
3039
TFS Financial
TFSL
$3.78B
| $434K | ﹤0.01% |
33,503
+6,132
| +22% | +$79.4K |
|
3040
ZimVie
ZIMV
$532M
| $434K | ﹤0.01% |
46,413
+18,439
| +66% | +$172K |
|
3041
Kingsway Financial Services
KFS
$416M
| $433K | ﹤0.01% |
32,034
+18,253
| +132% | +$247K |
|
3042
Aura Biosciences
AURA
$412M
| $429K | ﹤0.01% |
68,551
+18,156
| +36% | +$114K |
|
3043
United States Natural Gas Fund
UNG
$575M
| $429K | ﹤0.01% |
28,118
+17,153
| +156% | +$262K |
|
3044
Gencor Industries
GENC
$227M
| $428K | ﹤0.01% |
30,607
+9,146
| +43% | +$128K |
|
3045
Rocket Pharmaceuticals
RCKT
$354M
| $428K | ﹤0.01% |
174,438
+7,556
| +5% | +$18.5K |
|
3046
American Vanguard Corp
AVD
$159M
| $427K | ﹤0.01% |
108,882
+18,201
| +20% | +$71.4K |
|
3047
First Community Corp
FCCO
$216M
| $427K | ﹤0.01% |
17,528
+4,579
| +35% | +$112K |
|
3048
The Joint Corp
JYNT
$156M
| $427K | ﹤0.01% |
37,046
+15,083
| +69% | +$174K |
|
3049
Annexon
ANNX
$279M
| $426K | ﹤0.01% |
177,628
+12,496
| +8% | +$30K |
|
|
FFAI
3050
Faraday Future Intelligent Electric Inc. Common Stock
FFAI
$278M
| $426K | ﹤0.01% |
+253,780
| New | +$426K |
|